"Yesterday, we recommended the use of IL-6 receptor blockers, a type of monoclonal antibody, in patients with severe or critical #COVID19. This treatment, along with corticosteroids, is recommended for patients with severe or critical disease"-@DrTedroshttps://t.co/32Wum8HJYX

— World Health Organization (WHO) (@WHO) July 7, 2021